Apolipoprotein J Attenuates Vascular Restenosis by Promoting Autophagy and Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells
- PMID: 35244876
- DOI: 10.1007/s12265-022-10227-y
Apolipoprotein J Attenuates Vascular Restenosis by Promoting Autophagy and Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells
Abstract
This research investigated the mechanism of CLU in vascular restenosis by regulating vascular smooth muscle cell (VSMC) proliferation and migration. Firstly, rat models of balloon injury (BI) were established, followed by the assessment of the injury to the common carotid artery. The effect of CLU on the intimal hyperplasia of BI rats was measured after the intervention in CLU, in addition to the evaluation of proliferation, migration, and autophagy of VSMCs. Moreover, the interaction between ATG and LC3 was analyzed, followed by validation of the role of autophagy in CLU's regulation on the proliferation and migration of VSMCs. It was found that CLU was highly expressed in BI rats. Altogether, our findings indicated that CLU was highly expressed in vascular restenosis, and CLU over-expression promoted the binding between ATG3 and LC3, thus facilitating VSMC autophagy and eventually attenuating intimal hyperplasia and vascular restenosis.
Keywords: Apolipoprotein J; Migration; Proliferation; Vascular restenosis; Vascular smooth muscle cells.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway.Food Funct. 2022 Nov 28;13(23):12077-12092. doi: 10.1039/d2fo02441a. Food Funct. 2022. PMID: 36367287
-
Nkx2-3 induces autophagy inhibiting proliferation and migration of vascular smooth muscle cells via AMPK/mTOR signaling pathway.J Cell Physiol. 2021 Nov;236(11):7342-7355. doi: 10.1002/jcp.30400. Epub 2021 Apr 30. J Cell Physiol. 2021. PMID: 33928642
-
N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.Biochem Biophys Res Commun. 2018 Feb 5;496(2):415-421. doi: 10.1016/j.bbrc.2018.01.015. Epub 2018 Jan 4. Biochem Biophys Res Commun. 2018. PMID: 29305859
-
Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.Mol Med Rep. 2019 Aug;20(2):1436-1442. doi: 10.3892/mmr.2019.10328. Epub 2019 Jun 4. Mol Med Rep. 2019. PMID: 31173198
-
Angiotensin II type 1 receptor-associated protein regulates carotid intimal hyperplasia through controlling apoptosis of vascular smooth muscle cells.Biochem Biophys Res Commun. 2018 Jan 8;495(2):2030-2037. doi: 10.1016/j.bbrc.2017.12.059. Epub 2017 Dec 13. Biochem Biophys Res Commun. 2018. PMID: 29247644
Cited by
-
Defective autophagy in vascular smooth muscle cells promote uremic accelerated atherosclerosis.Ren Fail. 2025 Dec;47(1):2538268. doi: 10.1080/0886022X.2025.2538268. Epub 2025 Aug 13. Ren Fail. 2025. PMID: 40804030 Free PMC article.
-
Colchicine reduces neointima formation and VSMC phenotype transition by modulating SRF-MYOCD activation and autophagy.Acta Pharmacol Sin. 2025 Apr;46(4):951-963. doi: 10.1038/s41401-024-01438-x. Epub 2024 Dec 11. Acta Pharmacol Sin. 2025. PMID: 39663419
-
Chinese medicine targets cellular autophagy against cardiovascular diseases: research progress and future prospects.Front Cardiovasc Med. 2025 May 26;12:1585407. doi: 10.3389/fcvm.2025.1585407. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40491718 Free PMC article. Review.
-
The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing.Int J Mol Sci. 2023 Aug 24;24(17):13182. doi: 10.3390/ijms241713182. Int J Mol Sci. 2023. PMID: 37685987 Free PMC article. Review.
References
-
- Anderson, L., Thompson, D. R., Oldridge, N., et al. (2016). Exercise-based cardiac rehabilitation for coronary heart disease. The Cochrane Database of Systematic Reviews, 2016(1):CD001800. https://doi.org/10.1002/14651858.CD001800.pub3
-
- Jeong, Y. J., Ahn, J. M., Hyun, J., et al. (2021). Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study. Journal of the American Heart Assocation, 10, e019834. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous